This study is an animal experiment using beagle dogs and was performed following the Science Council of Japan guidelines for animal experimentation. We obtained approval from the ethics committee for Animal Experimentation of Osaka Prefecture University, Japan.
Five healthy beagle dogs, two spayed female dogs and three sexually intact male dogs, weighing approximately 10–12 kg, were evaluated and experimented in the operating room of same facility. Three of five dogs were used for repeated experiments, for a total of nine experiments. The dogs used twice received with a minimum 21-days period between experiments. The beagle dogs were purchased from Oriental Yeast Co., Ltd. in Tokyo, Japan, and bred in Osaka Prefecture University. They were housed in separate cages, in which the temperature was maintained at 23±1℃ and the light/dark cycle of time was 12 hours. Feeding was once a day and water was available freely. All dogs were judged to be in good to excellent health based upon a physical examination, blood examination and chest radiography before each experiment by veterinarians. Food was withheld for at least 12hr before drug administration, but the dogs were allowed free access to water prior to each experiment.
Firstly, anesthesia was induced to the beagle dogs. We inserted a cannula into the peripheral vein and administered butorphanol tartrate continuously at a rate of 0.1 mg/kg/h. Subsequently, we administered the subcutaneous injection of 0.025 mg/kg atropine and intravenous injection of 0.5 mg/kg of diazepam during preoxygenation. While starting administration of propofol continuously at a rate of 8–16 mg/kg/h, we intubated the dogs with a cuffed endotracheal tube, with an internal diameter of 6.0–7.0 mm, after introducing anesthesia. After administration of neuromuscular blockade agents (1.0-mg/kg bolus of rocuronium bromide) with train-of-four monitoring, they were mechanically ventilated using a pressure-controlled mode with 50% oxygen, peak inspiratory pressure of 5–7 cm H2O, inspiration to expiration ratio of 1:2, PEEP of 0 cmH2O, and respiratory rate of 20 breaths/min (Evita 4, Dräger Medical, Lübeck, Germany). Before measurement, we adjusted the respiratory rate to maintain end-tidal CO2 within 35–45 mmHg.
We inserted a cannula into the tarsal artery and continuously measured the arterial pressure and SVV using the Vigileo-FloTracTM system (Edwards Lifesciences, Irvine, CA, USA). SVV was calculated based on an arterial pulse contour analysis, converting the animals’ age to human terms and adjusting the body surface area according to the conversion table by Nelson et al.14 A thermodilution catheter (132F5, Edwards Lifesciences, Irvine, CA, USA) was inserted through an introducer (RR-A60G10S, TERUMO, Tokyo, Japan) into the right internal jugular vein. We measured continuously the central venous pressure (CVP) and intermittently cardiac output derived by the thermodilution method (COtd), injecting 5 mL of saline solution at a temperature of <8 °C through a thermodilution catheter. SV derived from a thermodilution method (SVtd) was calculated using the formula: SVtd = COtd / HR × 1,000 (mL). After induction of anesthesia, we administrated 10 mL/kg of hydroxyethyl starch to maintain the mean arterial pressure (MAP) at >60 mmHg and pulse rate within 100 beats/min to stabilize hemodynamics and prevent hypotension during the experiment.
We prepared the following three preload conditions: baseline model, mild hemorrhage model, and moderate hemorrhage model. First, we removed 10 ml/kg of blood via an introducer catheter (mild hemorrhage model), then subsequently removed an additional 10 ml/kg of blood (moderate hemorrhage model).
We measured each parameter under varying ventilation settings and preloads. First, under the baseline model, driving pressure was incrementally increased by 4 cm H2O, from 5 to 17 cmH2O, under PEEP of 4, 8, and 12 cm H2O. The higher limit of peak airway pressure was set to 21 cmH2O to avoid injury to the dogs’ lung. We observed for at least 2 min between steps to stabilize the hemodynamics (Figure 1). We recorded SVV, CVP, MAP, COtd, heart rate (HR), and tidal volume (Vt) as baseline parameters under each ventilation setting. The CVP, MAP, and HR were obtained from the patient monitor (BP-608 Evolution II, Omron Colin, Tokyo, Japan). The COtd measurements were performed using the thermodilution method three times at driving pressure of 5, 13, and 17 cm H2O, to avoid fluid loading. Under the mild and moderate hemorrhage models, we repeated the measurements in the same manner mentioned above. At the end of the experiment, the beagle dogs were carefully re-infused with removed blood, which was temporarily stored in a blood bag during measurement. The beagle dogs were followed up for a minimum 21-days period between experiments. All dogs were not euthanized, because a blood transfusion of 20 ml/kg at intervals more than 21-days is acceptable in the veterinary clinically.15
All data were presented as the mean±standard deviation (SD) or median (with interquartile range). We analyzed all data using the JMP Pro 12 software program for Windows (SAS Institute Inc., Cary, NC, USA). Correlations between more than two variables were analyzed using a linear regression model based on the least-squares method. The univariate analysis was used to analyze the effect of the relationship between PEEP and hemorrhage, driving pressure, and hemorrhage on SVV. We entered hemorrhage, PEEP, and driving pressure as covariates and performed a multivariate regression analysis to understand the factor affecting SV and SVV. Differences were considered significant for p values <0.05.